Oscar Health (NYSE:OSCR) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Oscar Health (NYSE:OSCR) released its quarterly earnings results on Thursday. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02, Zacks reports. The firm had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 20.84%. The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.22) EPS. Oscar Health updated its FY 2025 guidance to EPS.

Oscar Health Stock Up 6.9%

Shares of NYSE:OSCR traded up $1.14 during trading hours on Friday, hitting $17.70. The company’s stock had a trading volume of 24,640,823 shares, compared to its average volume of 14,876,280. The firm’s fifty day moving average price is $19.17 and its 200 day moving average price is $16.81. Oscar Health has a 52 week low of $11.20 and a 52 week high of $23.80. The company has a market capitalization of $4.58 billion, a price-to-earnings ratio of -15.81 and a beta of 1.88. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86.

Wall Street Analyst Weigh In

OSCR has been the topic of a number of recent analyst reports. Barclays reduced their price objective on shares of Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 23rd. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Wells Fargo & Company raised their price target on Oscar Health from $10.00 to $14.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 7th. Wall Street Zen downgraded Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, August 9th. Finally, Baird R W lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Six analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Oscar Health currently has an average rating of “Reduce” and an average price target of $13.29.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 24.39% of the stock is currently owned by insiders.

Institutional Trading of Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. Strs Ohio bought a new position in shares of Oscar Health in the 1st quarter worth $30,000. Jones Financial Companies Lllp grew its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the last quarter. Binnacle Investments Inc bought a new position in Oscar Health in the second quarter worth about $75,000. Baird Financial Group Inc. purchased a new stake in shares of Oscar Health during the first quarter valued at about $159,000. Finally, Cerity Partners LLC lifted its position in shares of Oscar Health by 11.6% during the second quarter. Cerity Partners LLC now owns 11,256 shares of the company’s stock valued at $241,000 after buying an additional 1,167 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.